Skip to main content

Table 3 Previously characterized large rearrangements that were included in the study

From: Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk

Gene

Mutation

microarray CGH

NGS dosage analysis

MLPA

APC

deletion promoter 1B - exon 3

detected

detected

n/a

deletion exon 4

detected

detected

n/a

BRCA1

duplication promoter 1A - exon 2

detected

detected

n/a

deletion promoter 1A - exon 19

detected

detected

n/a

duplication exons 5 - 7

detected

detected

n/a

deletion exon 13

detected

n/a -- insufficient volume

n/a

duplication exon 13

detected

detected

n/a

deletion exons 15 – 16

detected

n/a -- insufficient volume

n/a

deletion exons 16 - 17

detected

detected

n/a

deletion exon 24

detected

detected

n/a

BRCA2

duplication exons 12 - 13

detected

detected

n/a

EPCAM

deletion exons 2 - 3' UTR

detected

detected

n/a

MLH1

deletion exons 4 - 9

detected

detected

n/a

deletion exon 13

detected

detected

n/a

deletion exon 14

detected

detected

n/a

deletion exon 16

detected

detected

n/a

MSH2

deletion exon 1

detected

detected

n/a

deletion exons 1 - 6

detected

No Result

n/a

duplication exons 1 - 6

detected

detected

n/a

deletion exons 1 - 7

detected

detected

n/a

deletion exons 1 - 8

detected

detected

n/a

deletion exons 1 - 10

detected

detected

n/a

deletion exons 8 - 15

detected

detected

n/a

deletion exon 16

detected

detected

n/a

MSH6

deletion exons 4 (3' end) - 10

detected

detected

n/a

MUTYH

duplication exon 1

detected

detected

n/a

PMS2

deletion exon 10

n/a

n/a

detected

deletion exons 1 - 5

n/a

n/a

detected

deletion exons 13 - 14

n/a

n/a

detected

deletion exons 14 - 15

n/a

n/a

detected

deletion exons 9 - 11

n/a

n/a

detected